China favors first nasal spray COVID-19 antibody for preliminaries Kumar Jeetendra | September 10, 2020 China has approved for trials its initial nasal spray vaccine to combat the novel coronavirus that has claimed over 904,000 lives and infected more than 27 million people globally, official media here reported on September 10. China’s only nasal spray vaccine against the coronavirus is anticipated to start phase I clinical trials in November, and …
China’s Sinovac is sheltered, says Brazil’s leading research organization Kumar Jeetendra | October 20, 2020 São Paulo’s Butantan Institute, one of Brazil’s leading biomedical research centers, which is carrying out the Stage 3 tests, said the two-dose vaccine, called CoronaVac, was secure in a trial thus far involving 9,000 volunteers. But Butantan manager Dimas Covas said data on how effective the vaccine is will not be published until the trial …
China doubles down on COVID account as WHO examination looms Kumar Jeetendra | January 5, 2021 As a team from the World Health Organization (WHO) prepares to go to China to investigate the origins of COVID-19, Beijing has stepped up efforts not only to prevent new outbreaks, but also form the story about when and where the pandemic began. China has dismissed criticism of its early handling of the coronavirus, first …
